How to Order Venofer (Iron Sucrose) Infusion
Order Venofer based on the patient's CKD status: for hemodialysis patients give 100 mg IV over 2-5 minutes or diluted in 100 mL normal saline over 15 minutes per dialysis session; for non-dialysis CKD give 200 mg IV over 2-5 minutes or diluted in 100 mL normal saline over 15 minutes, repeated 5 times over 14 days; for peritoneal dialysis patients give 300 mg over 1.5 hours on days 1 and 15, then 400 mg over 2.5 hours on day 29. 1
Dosing by Patient Population
Hemodialysis-Dependent CKD (HDD-CKD)
- Dose: 100 mg per dialysis session
- Administration options:
- Undiluted slow IV push over 2-5 minutes, OR
- Diluted in maximum 100 mL 0.9% NaCl over at least 15 minutes
- Timing: Give early in dialysis session (within first hour)
- Total course: 1000 mg total (10 doses)
- Repeat: When iron deficiency recurs 1
Non-Dialysis-Dependent CKD (NDD-CKD)
- Dose: 200 mg per infusion
- Administration options:
- Undiluted slow IV push over 2-5 minutes, OR
- Diluted in maximum 100 mL 0.9% NaCl over 15 minutes
- Frequency: 5 doses over 14 days
- Alternative regimen (limited experience): 500 mg diluted in maximum 250 mL 0.9% NaCl over 3.5-4 hours on days 1 and 14 1
Peritoneal Dialysis-Dependent CKD (PDD-CKD)
- Regimen: 3 divided doses over 28 days
- 300 mg over 1.5 hours on day 1
- 300 mg over 1.5 hours on day 15
- 400 mg over 2.5 hours on day 29
- Dilution: Maximum 250 mL 0.9% NaCl 1
Pediatric Patients (≥2 years)
- HDD-CKD maintenance: 0.5 mg/kg (max 100 mg) every 2 weeks for 12 weeks
- NDD-CKD or PDD-CKD on EPO: 0.5 mg/kg (max 100 mg) every 4 weeks for 12 weeks
- Administration: Undiluted over 5 minutes OR diluted in 0.9% NaCl at 1-2 mg/mL over 5-60 minutes
- Critical: Do not dilute below 1 mg/mL 1
Key Ordering Details
Each mL of Venofer contains 20 mg elemental iron - this is crucial for calculating volumes. The product comes as 100 mg/5 mL single-dose vials. 1
Safety Considerations
Start all infusions slowly and observe for several minutes before completing the infusion. Minor infusion reactions occur in 1-3% of patients and typically resolve without intervention. 2
Critical Safety Points:
- Do NOT treat minor infusion reactions with vasopressors or H1 blockers - this converts benign complement activation-related pseudo-allergy into hemodynamically significant events 2
- Serious adverse events are vanishingly rare with proper administration 2
- The 2-minute push technique (200 mg over 2 minutes) has been studied in 2,297 injections with only 2.5% adverse events, most being transient metallic taste (17.9%) 3
Common Pitfalls to Avoid
Dosing too rapidly: The original rapid injection protocols caused unnecessary reactions. Slower administration (15+ minutes for infusions) dramatically reduces adverse events 2
Wrong dose for wrong population: Maximum safe single doses vary - 200-300 mg is well-tolerated, but 400-500 mg doses have higher reaction rates when given over 2 hours 4. The FDA-approved regimens above are optimized for safety.
Inappropriate dilution in pediatrics: Never dilute below 1 mg/mL concentration in children 1
Overreacting to minor infusion reactions: Most reactions are self-limited and require only observation or slowing the infusion rate 2
Monitoring After Administration
Check CBC and iron parameters (ferritin, transferrin saturation) 4-8 weeks after the last infusion - not sooner, as circulating iron interferes with assays. Hemoglobin should increase 1-2 g/dL within 4-8 weeks. 2